Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, ...
Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain. Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), ...
1Division of Infectious Diseases, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. 2Center for Human Immunobiology, Department of Medicine, Feinberg ...
Divarasib plus cetuximab is well tolerated in patients with KRAS G12C-positive colorectal cancer.
Cancer Res (2025) 85 (18_Supplement_3): B001.
1Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany. 2Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer ...
1Yonsei University, College of Medicine, Seoul, Republic of Korea.
1Cancer Biology and Genetics Program, Sloan Kettering Institute, New York, New York.
Institute of TCM-X/MOE Key Laboratory of Bioinformatics, Bioinformatics Division, BNRist/Department of Automation, Tsinghua University, Beijing, China.
Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland.
Abstract. Macrophages are a type of immune cell that play a crucial role in the tumor microenvironment. In tumors, macrophages can be polarized towards a pro-inflammatory phenotype, referred to as M1, ...
1AstraZeneca, ICC, Early Oncology, R&D, Cambridge, United Kingdom.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results